CUSTOMS Notification No. 83 of 2017 dt 31st October, 2017

 

Notification no. 83/2017 Customs date on 31st October, 2017

  

Seeks to amend notification No. 16/2017-Customs dated the 20th April, 2017.

  

The extract of CUSTOMS Notification No. 83/2017- CUSTOMS is given below:

 

Notification No. 83/2017-CUSTOMS

  

[TO BE PUBLISHED IN THE GAZETTE OF INDIA, EXTRAORDINARY, PART II, SECTION 3, SUB-SECTION (i)]

 

GOVERNMENT OF INDIA

MINISTRY OF FINANCE

(DEPARTMENT OF REVENUE)

 

Notification No. 83 /2017-Customs

 

New Delhi, the 31st October, 2017

 

G.S.R. (E). - In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, on being satisfied that it is necessary in the public interest so to do, hereby makes the following further amendments in the notification of the Government of India, in the Ministry of Finance (Department of Revenue), No. 16/2017-Customs, dated the 20th April, 2017, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R.394 (E), dated the 20th April, 2017, namely: -

 

In the said notification, in the Table, after serial number 27 and the entries relating thereto, the following serial numbers and entries shall be added, namely: -

 

(1)

(2)

(3)

(4)

“28.

Erlotinib

The Blue Tree

Roche Products

 

(Tarceva)

 

(India) Private Limited

29

Trastuzumab

The Blue Tree

Roche Products

 

(Herclon)

 

(India) Private Limited

30.

Pertuzumab (Perjeta)

The Blue Tree

Roche Products

 

 

 

(India) Private Limited

31.

Transtuzumab

The Blue Tree

Roche Products

 

Emtansine

 

(India) Private Limited

 

(Kadcyla)

 

 

32.

Obinutuzumab

The Blue Tree

Roche Products

 

(Gazyva)

 

(India) Private Limited

33.

Bevacizumab

The Blue Tree

Roche Products

 

(Avastin)

 

(India) Private Limited

34.

Tocilizumab

Care  for Joints

Roche Products

 

(Actemra)

 

(India) Private Limited

35.

Mycophenolate

Aarambh

Roche Products

 

Mofetil

 

(India) Private Limited

 

(CellCept)

 

 

36.

Avonex   (Interferon

Reach

UCB India Private Limited

 

Beta 1A)

 

 

37.

Tysabri

Reach

UCB India Private Limited

 

(Monoclonal

 

 

 

Antibody

 

 

38.

Tecfidera (Di-

Reach

UCB India Private Limited

 

methyl Fumarate)

 

 

39.

Plegridy

Reach

UCB India Private Limited

 

 

 

(Peggylated

 

 

 

 

 

 

 

 

 

Interferon Beta 1A)

 

 

 

 

 

 

 

 

40.

Sorafenib

NexCSP

(Nexavar

Cancer

Bayer Zydus

 

 

(Nexavar)

Survivorship Program)

Pharma Private Limited

41.

Sirturo

Bedaquiline

Compassionate

Janssen India,

 

 

(Bedaquiline)

Use Program

 

 

 

Johnson  &  Johnson

Private

 

 

 

 

 

 

 

 

Limited

 

42.

Darzalex

Daratumumab

 

Patient

Janssen India,

 

 

(Daratumumab)

Assistance Program

 

Johnson  &  Johnson

Private

 

 

 

 

 

 

 

 

Limited

 

43.

SUTENT

- Patients initially pay for 12

Pfizer Products India Private

 

 

strips (value equivalent of 50

Limited

 

 

 

mg) and gets assistance of 12

 

 

 

 

strips free.

 

 

 

 

 

 

 

 

- Post purchase of 12 strips

 

 

 

 

patients receive the drug free

 

 

 

 

until

prescribed

by

treating

 

 

 

 

physicians.

 

 

 

 

 

 

 

-Full   subsidy   for   BPL

 

 

 

 

patients

 

 

 

 

 

 

44.

CRIZALK

Patients will pay for 8 bottles

Pfizer Products India Private

 

 

(either 200 mg or 250 mg)

Limited

 

 

 

and  post  that  will  get  the

 

 

 

 

drug free until prescribed by

 

 

 

 

treating physician.

 

 

 

 

 

-  Full  subsidy  for  BPL

 

 

 

 

patients

 

 

 

 

 

 

45.

INLYTA

Sutent

Patients

who

Pfizer Products India Private

 

 

progresses

and

prescribed

Limited

 

 

 

lnlyta as 2nd line pays for 1

 

 

 

 

strip and gets 1 strip free.

 

 

 

 

- Patients who progresses on

 

 

 

 

other 1st line TKI pays for 2

 

 

 

 

strips and get 1 strip free.

 

 

 

 

-Ful1subsidy

 

for

BPL

 

 

 

 

patients

 

 

 

 

 

 

46.

PALBACE

-Patients  will  pay  for  10

Pfizer Products India Private

 

 

cycles and post that will get

Limited

 

 

 

free

drug

support   until

 

 

 

 

prescribed

 

by

 

treating

 

 

 

 

physicians.

 

 

 

 

 

 

 

-  Full  subsidy  for  BPL

 

 

 

 

patients

 

 

 

 

 

 

 

 

ENLIVEN

 

 

 

 

 

 

 

-Enbrel  50  mg:  4+2PAP.

 

 

 

 

Any further repeat purchase

 

 

47.

ENBREL

will  be  given  at  a  further

Pfizer Limited

 

 

 

discounted price

 

 

 

 

 

 

 

 

-Enbrel25mg: 8+4 PAP. Any

 

 

 

further repeat purchase will

 

 

 

be   given   at   a   further

 

 

 

discounted price

 

 

 

XELSOURCE

 

48.

XELJANZ

India  specific  price  of  Rs.

Pfizer Limited

 

 

24000 per bottle (MRP is Rs.

 

 

 

66000 per bottle)

 

49.

GENPTROPIN

5+1 PAP

Pfizer Products India Private

 

 

 

Limited

 

 

For AIIMS Delhi 5+1, KEM

Pfizer Products India Private

50.

Atgam

Mumbai 4+1, CMC Vellore

Limited

 

 

4+1 & Other hospitals 20+4

 

51.

Aromasin

PAP 1+1

Pfizer Products India Private

 

 

 

Limited

52.

Campto

PAP 1+1

Pfizer Products India Private

 

 

 

Limited”.

 

[F. No. 332/24/2010-TRU (Pt. I)]

 

 

(Ruchi Bisht)

 

Under Secretary to the Government of India

 

 

Note: The principal notification No. 16/2017-Customs, dated the 20th April, 2017, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R.394 (E), dated the 20th April, 2017.


Discussion Forum

You can also share your thoughts about this article.
Any one can answer on question posted by Readers